e-Article
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
Document Type
Article
Author
Coombes, RC; Kilburn, LS; Snowdon, CF; Paridaens, R; Coleman, RE; Jones, SE; Jassem, J; Van de Velde, CJH; Delozier, T; Alvarez, I; Del Mastro, L; Ortmann, O; Diedrich, K; Coates, AS; Bajetta, E; Holmberg, SB; Dodwell, D; Mickiewicz, E; Andersen, J; Lønning, PE; Cocconi, G; Forbes, J; Castiglione, M; Stuart, N; Stewart, A; Fallowfield, LJ; Bertelli, G; Hall, E; Bogle, RG; Carpentieri, M; Colajori, E; Subar, M; Ireland, E; Bliss, JM
Source
In The Lancet 2007 369(9561):559-570
Subject
Language
ISSN
0140-6736